Fredun Pharmaceuticals Ltd — Updates, 31-05-2025: Company Update

Fredun Pharmaceuticals has announced a board meeting on which it approved the financial results for the quarter and half-year ended March 31, 2025. The company reported standalone net sales of Rs. 165.44 Cr and a profit after tax of Rs. 7.07 Cr for the quarter, with full-year PAT at Rs. 20.81 Cr. Earnings per share stood at Rs. 14.98 for the quarter and Rs. 44.17 for the year. The Board has proposed a final dividend of 7% per share, subject to shareholder approval. Consolidated results include newly added subsidiaries Fredun Retail Pvt Ltd and One Pet Stop Pvt Ltd. Statutory auditors issued unmodified audit opinions. Note: The company has delayed transferring unclaimed dividends and related shares from FY 2015-16 and FY 2016-17 to the Investor Education and Protection Fund.